Cdk4/6 Inhibitors and Overall Survival: Power of First-Line Trials in Metastatic Breast Cancer
npj Breast Cancer - United Kingdom
doi 10.1038/s41523-018-0068-4
Full Text
Open PDFAbstract
Available in full text
Date
June 26, 2018
Authors
Publisher
Springer Science and Business Media LLC